ASP Isotopes Inc. (ASPI)
- Previous Close
3.0400 - Open
3.0000 - Bid 3.0600 x 200
- Ask 3.1200 x 300
- Day's Range
2.9100 - 3.2180 - 52 Week Range
0.2800 - 4.9670 - Volume
871,395 - Avg. Volume
652,714 - Market Cap (intraday)
160.488M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.4900 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
5.50
ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.
aspisotopes.comRecent News: ASPI
Performance Overview: ASPI
Trailing total returns as of 4/18/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ASPI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ASPI
Valuation Measures
Market Cap
160.23M
Enterprise Value
154.46M
Trailing P/E
--
Forward P/E
54.35
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
235.58
Price/Book (mrq)
9.83
Enterprise Value/Revenue
356.71
Enterprise Value/EBITDA
-9.57
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-50.08%
Return on Equity (ttm)
-113.75%
Revenue (ttm)
433.03k
Net Income Avi to Common (ttm)
-16.29M
Diluted EPS (ttm)
-0.4900
Balance Sheet and Cash Flow
Total Cash (mrq)
7.91M
Total Debt/Equity (mrq)
11.38%
Levered Free Cash Flow (ttm)
-1.62M
Research Analysis: ASPI
Analyst Price Targets
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell